ZBTB3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-80367
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptide directed towards the N terminal of human ZBTB3. Peptide sequence MLREFSKWGVEASPGKAWERKRSLLRGAVGRYRGATGGDLFWAPFPSWGT. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for ZBTB3 Antibody
![Western Blot: ZBTB3 Antibody [NBP1-80367]](https://resources.bio-techne.com/images/products/ZBTB3-Antibody-Western-Blot-NBP1-80367-img0002.jpg "Western Blot: ZBTB3 Antibody [NBP1-80367]")
Western Blot: ZBTB3 Antibody [NBP1-80367]
Western Blot: ZBTB3 Antibody [NBP1-80367] - HepG2 cell lysate, concentration 0.2-1 ug/ml.Applications for ZBTB3 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ZBTB3
Alternate Names
FLJ23392, zinc finger and BTB domain containing 3, zinc finger and BTB domain-containing protein 3
Gene Symbol
ZBTB3
UniProt
Additional ZBTB3 Products
Product Documents for ZBTB3 Antibody
Product Specific Notices for ZBTB3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...